What percentage of people experience side effects from Wegovy?

The myth: if most people get side effects, that means Wegovy is unsafe

This is the misreading that sends a lot of people spiralling into forum threads at midnight. High incidence numbers for side effects in drug trials do not equal high danger. Clinical trials count every reported symptom, a single day of mild nausea counts the same as a hospitalisation in the raw percentage. In the STEP 1 study, published in the New England Journal of Medicine, the overwhelming majority of side effects were gastrointestinal, graded mild or moderate, and a large share resolved without any change to treatment. Rates in the placebo group were also high, the gap between the two arms tells you more than the headline number alone.

That said, minimising it doesn't serve you either. Some people find the first four to eight weeks genuinely uncomfortable. Nausea can be persistent. Vomiting happens. The question our prescribers ask is not whether you might feel rough temporarily, but whether your health profile makes that temporary discomfort the right trade-off, and whether there are factors that raise your individual risk of something more serious. Both things can be true: common side effects are usually manageable, and rare ones deserve your full attention.

The full Wegovy side-effect picture is more layered than any single percentage captures. Understanding what's common versus what's urgent changes how you approach the first few months on treatment.

What side effects actually show up, and how often

The GI effects dominate the data. If you want to see how those wegovy side effects break down by percentage, the figures from STEP 1 show nausea affecting roughly 44% of participants on semaglutide 2.4mg compared to around 16% on placebo, with diarrhoea, vomiting, constipation and indigestion each showing up in a meaningful minority. Fatigue, headache, dizziness and injection-site reactions were also reported, though less commonly. The NHS patient information for semaglutide lists these in plain language and is worth bookmarking before you start.

The pattern matters as much as the percentage. Side effects cluster around two moments: first, when you start treatment at the lowest dose, and second, each time the dose steps up. For most people this means a predictable rhythm of settling and adjustment rather than a constant background hum of symptoms. Eating smaller portions, staying well hydrated and not eating high-fat foods in the period around your injection all make a practical difference, though the exact advice should come from your prescriber and the Patient Information Leaflet, not a web page.

If you want to understand whether most people experience side effects from Wegovy in the first place (and what separates those who sail through from those who struggle) that's a question worth exploring before you start. The honest answer is that individual variation is real and not fully predictable in advance.

When to get medical help, and what to watch for

Most people reading this page are doing research, not sitting in an emergency. But this section matters, so it gets said clearly. In January 2026, the MHRA issued a Drug Safety Update specifically flagging acute pancreatitis as a known, infrequent but serious side effect of GLP-1 medicines including semaglutide. The symptom to act on immediately is severe, persistent stomach pain that spreads to your back, with or without vomiting. That is a 999 call or an urgent trip to A&E, not a wait-and-see situation.

Other reasons to contact a doctor or 111 without delay: signs of a serious allergic reaction (swelling of the face, throat or tongue; difficulty breathing; rapid heartbeat); gallbladder problems (pain in the upper right abdomen, fever, jaundice); or severe vomiting or diarrhoea that is preventing you from keeping any fluids down, because dehydration can follow quickly and affect your kidneys. Sudden changes to your vision should also prompt urgent advice if you have a diabetes diagnosis alongside your weight management treatment.

Low mood or thoughts of self-harm are listed on the label because they were reported in trials; they are uncommon, but tell someone and seek help if they appear. The complete guide to Wegovy's side effects covers each of these in more detail, with the MHRA's guidance cited throughout. And remember: you can report anything you suspect is linked to your treatment at yellowcard.mhra.gov.uk, your report contributes to the ongoing safety picture for these medicines nationally.

What this means if you're weighing up whether to start

If you're sitting with a list of statistics and feeling uncertain, that's a completely reasonable place to be. These are not trivial medicines and the decision deserves proper thought. The side-effect percentages from trials represent a population average; your individual picture depends on factors a trial average cannot capture, including your current health conditions, any other medicines you take, and how your body tends to respond to changes in how it processes food and regulates appetite.

That's precisely why a prescriber reviews every consultation at nume in person, reading your full health history rather than running it through a filter. If you're exploring treatment options more broadly, the weight-loss treatments page sets out what's available and how the consultation process works. For those curious about the minority who seem to experience no effects at all, that question has its own answer and it's a more nuanced one than you might expect. Side effects are one part of the clinical picture; how treatment is managed and monitored through aftercare is another, and it's where the difference between services shows up in practice.